|
|
| MRD / Regn No. |
: 20260000363 |
Date |
: 24/07/2026 |
| Patient Name |
: Simo Aung Aunglwin |
Age & Gender |
: 52 Yrs. / Male |
| Contact No. |
: 8939442624 |
UHID |
: |
| Ht / Wt / BMI |
: 178 / 103 / 32.51 |
BP S / BP D |
: / |
| Allergies |
: NKA |
Referred By |
: |
| |
|
|
Subjective |
: |
DM FOR 10 YEARS,PCI 2024
|
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,OBSTRUCTIVE SLEEP APNEA,VITAMIN D DEFICEINCY |
|
Plan |
: |
INCREASE TIRZEPATIDE 7.5 MG,SEE ME IN 2 MONTHS |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 133 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 173 mg/dL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
SGLT2I EMPAGLIFLOZIN 10 MG JARDIANCE Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
2 |
INJECTION TIRZEPATIDE 7.5 MG MOUNJARO Medicine For DIABETES OBESITY |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 22/Sep/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP HBA1C |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription |
Powered By:  |